Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial

• 主要な著者: Kirti S Pawar (著者), Rahul N Mastud (著者), Satheesh K Pawar (著者), Samragni S Pawar (著者), Rahul R Bhoite (著者), Ramesh R Bhoite (著者), Meenal V Kulkarni (著者), Aditi R Deshpande (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Coronavirus disease-2019 (COVID-19) has a wide range of pathophysiological effects. Curcumin, an active constituent of Curcuma longa (turmeric), has several properties, including anti-inflammatory, antioxidant, antiviral, anti-thrombotic, and anti-proliferative effects, which make it a p...